Selected Publication:
Baulmann, J; Düsing, R; Vetter, H; Mengden, T.
Therapy resistant hypertension--significance of electronic compliance monitoring].
Dtsch Med Wochenschr. 2002; 127(45):2379-2382
Doi: 10.1055/s-2002-35355
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
-
Baulmann Johannes
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
-
A 71-year-old woman was admitted with arterial hypertension resistant to drug therapy (office readings 197/82 mmHg) under medication with beta-blocker, AT 1 -antagonist and a diuretic. The only physical pathologic finding was an adipositas.
The patient was suffering from isolated systolic hypertension, grade 3 corresponding to WHO-guidelines. Despite antihypertensive triple therapy office as well as self-measured blood pressure values (mean 170/82 mmHg) remained elevated. Thus, the patient fulfilled the criteria of a resistant hypertension. The degree of compliance was only 50 %, detected by using a Medication-Event-Monitoring-System (correct dosing interval 17.1 %). We discussed the results of compliance- and blood pressure self-measurement with the patient. In the following period of compliance- and blood pressure self-measurement (with unchanged antihypertensive therapy) the compliance increased dramatically with a degree of 90,9 % and self-measured blood pressure values almost normalized (mean 137/71 mmHg).
The control of compliance by using electronic compliance-monitoring may help to discover non-compliance as a frequent cause of resistant hypertension and to avoid unnecessary cost-extensive procedures.
- Find related publications in this database (using NLM MeSH Indexing)
-
Aged -
-
Antihypertensive Agents - administration & dosage
-
Antihypertensive Agents - therapeutic use
-
Blood Pressure Monitors - utilization
-
Drug Monitoring - instrumentation
-
Drug Therapy, Combination -
-
Female -
-
Humans -
-
Hypertension - diagnosis
-
Hypertension - drug therapy
-
Patient Compliance -